The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

Dubai Police impounds 497 vehicles over unpaid traffic fines
UAE to train more than 24,000 educators ahead of new academic year
UAE convoys carrying 800 tonnes of aid enter Gaza
UAE places youth at heart of development journey: Sultan Al Neyadi
